Results 221 to 230 of about 640,835 (387)
Opioid-mediated suppression of cultured peripheral blood mononuclear cell respiratory burst activity. [PDF]
Phillip K. Peterson+4 more
openalex +1 more source
In‐hospital and 1 year incremental prognostic value of drug abuse detection in acute heart failure
Abstract Aims The study aims to assess the in‐hospital and 1 year incremental prognostic value of recent drug abuse use, detected by a systematic urinary screening, in a consecutive cohort of patients hospitalized for acute heart failure (AHF). Methods All patients admitted for AHF with a drug abuse screening using a urinary assay were included in this
Charles Fauvel+110 more
wiley +1 more source
The Mediating Role of Psychological Flexibility and Inflexibility Between Impulsivity and Opioid Misuse in People With Chronic Noncancer Pain. [PDF]
Barrado-Moreno V+3 more
europepmc +1 more source
Centrally administered opioid peptides stimulate saccharin intake in nondeprived rats [PDF]
Blake A. Gosnell, Mark J. Majchrzak
openalex +1 more source
(A) Univariable receiver operating characteristic (ROC) curves for all biomarkers. (B) Kaplan–Meier curves for best cut‐point of mid‐regional pro‐adrenomedullin (MR‐proADM) for survival (n = 442). AUC, area under the curve; CI, confidence interval; HR, hazard ratio; hsTnT, high‐sensitivity troponin T; MR‐proANP, mid‐regional pro‐atrial natriuretic ...
Markus S. Anker+18 more
wiley +1 more source
Influences of analgesics on the opioid peptide system in the rat incisor pulp
Masato Kuroi+3 more
openalex +1 more source
Opioid antagonist (naltrexone) modulation of cerebellar development: histological and morphometric studies [PDF]
IS Zagon, McLaughlin Pj
openalex +1 more source
Current and novel biomarkers in cardiogenic shock
A summary of current and novel biomarkers and their potential stages of release in cardiogenic shock. The diagram illustrates the proposed release of the biomarkers during the different stages of cardiogenic shock: progression from cardiac dysfunction/stress, through to inflammation and end‐organ dysfunction.
Victor Galusko+5 more
wiley +1 more source